Ionically Cross-Linked Hydrogel Formation via Competitive Ligand Exchange

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for forming ionically cross-linked hydrogels face challenges such as rapid gelation, difficulty in controlling kinetics, and incompatibility with biomedical applications due to chemical modification and regulatory issues, particularly in achieving controlled release of cross-linking agents and maintaining biocompatibility.

Innovation Solution

A method using competitive ligand exchange, where a first solution containing a cross-linking agent and a first chelating agent is mixed with a second solution containing a displacing agent, allowing for controlled release of the cross-linking agent to form a cross-linked polymer hydrogel, utilizing a chelating agent with higher affinity for the displacing agent than the cross-linking agent, enabling precise control over gel formation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If ionic cross-linking is used to form hydrogels, then biocompatibility is improved, but gelation kinetics cannot be controlled

Engineering Contradiction:
ImprovebiocompatibilityVSAvoidgelation kinetics control
Core Design Contradiction:
ReliabilityVSDuration of action of moving object

Solution Approach 1:

The cross-linking agent is pre-complexed with a chelating agent in the first solution, creating a reservoir that releases the cross-linking agent gradually. This preliminary complex formation controls the timing and rate of gelation while maintaining biocompatibility, as the cross-linking agent is released only when needed during the mixing process.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The chelating agent acts as an intermediary between the cross-linking agent and the polymer. It temporarily binds the cross-linking agent, controlling its release rate, and then facilitates controlled transfer to the polymer chains. This intermediary mechanism enables precise control over gelation kinetics while preserving the biocompatibility of ionic cross-linking.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Duration of action of moving object

If chemical cross-linking is used to control gel formation kinetics, then gelation control is improved, but biocompatibility deteriorates

Engineering Contradiction:
Improvegel formation kinetics controlVSAvoidbiocompatibility
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The chelating agent serves as an intermediary that enables ionic cross-linking to proceed with controlled kinetics without requiring chemical modification of the polymer. It mediates between the cross-linking agent and polymer chains, allowing physical ionic bonding instead of chemical covalent bonding, thus maintaining biocompatibility while achieving kinetic control.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The system controls gelation kinetics by changing the release rate parameter of the cross-linking agent through chelation equilibrium. By adjusting the affinity between the chelating agent and cross-linking agent, the gelation rate can be controlled without altering the fundamental ionic cross-linking mechanism, preserving biocompatibility.

Inventive Principle:
Principle #35Parameter changes

3Speed

If rapid ionic gelation occurs, then gel formation speed is improved, but controllability deteriorates

Engineering Contradiction:
Improvegel formation speedVSAvoidgelation controllability
Core Design Contradiction:
SpeedVSDuration of action of moving object

Solution Approach 1:

The cross-linking agent is pre-bound to the chelating agent in solution, creating a controlled-release system. This preliminary complex formation ensures that when mixing occurs, gelation begins at a controlled rate rather than occurring instantly, allowing both speed and controllability to be optimized simultaneously.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The system dynamically controls gelation rate through the reversible chelation equilibrium. The cross-linking agent can be released and bound as conditions change during mixing, allowing the gelation process to be dynamically adjusted in real-time. This dynamic control enables optimized gel formation speed while maintaining controllability.

Inventive Principle:
Principle #15Dynamics

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for rapid and controlled gel formation, maintaining biocompatibility and regulatory compliance, enabling applications in biomedical and pharmaceutical fields with adjustable gelation kinetics and avoiding the limitations of existing methods.

Implementation Method 1

a first chelating agent; wherein the first chelating agent has a higher affinity for the displacing agent than the cross-linking agent

Methodology Applied
Scientific EffectChelation:

Implementation Method 2

competitive ligand exchange, where a first solution containing a cross-linking agent and a first chelating agent is mixed with a second solution containing a displacing agent

Methodology Applied
Scientific EffectLigand exchange: Ion Exchange

Implementation Method 3

ionic cross-linking is especially attractive since it does not require covalent modification of the polymer and offers a mild and reversible route to gel formation

Methodology Applied
Scientific EffectIonic cross-linking: Ion Repulsion/Attraction

Data Source

PatentUS11767402B2Methods of forming ionically cross-linked gels
Publication Date: 2023.09.26 NORDOVO BIOSCI AS
  • US11767402B2 patent drawing
  • US11767402B2 patent drawing
  • US11767402B2 patent drawing

AI summary

The present invention relates to the formation of gels. In particular, the present invention is directed to a method of forming a cross-linked polymer hydrogel using competitive ligand exchange.